SENSEI BIOTHERAPEUTICS INC (SNSE) Stock Balance Sheet
USA - NASDAQ:SNSE - US81728A2078 - Common Stock
8.005 USD
-1.01 (-11.25%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 12.56M | 9.99M | 13.01M | 17.80M | 7.20M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 16.07M | 31.34M | 52.75M | 89.30M | 140.50M | |||
| Receivables | null | null | null | null | null | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 944.00K | 594.00K | 1.49M | 1.40M | 900.00K | |||
| Total Current Assets | 29.57M | 41.93M | 67.25M | 108.60M | 148.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.19M | 3.38M | 7.04M | 9.70M | 4.60M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | null | null | null | |||
| Other Non-Current Assets | 24.00K | 48.00K | 86.00K | 100.00K | 0 | |||
| Total Non-Current Assets | 2.21M | 3.43M | 7.12M | 9.80M | 4.70M | |||
| TOTAL ASSETS | 31.78M | 45.36M | 74.37M | 118.40M | 153.20M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 341.00K | 732.00K | 872.00K | 900.00K | 700.00K | |||
| Accrued Expenses | 3.10M | 4.35M | 3.08M | 3.70M | 1.80M | |||
| Accounts Payable | 351.00K | 244.00K | 1.69M | 4.50M | 2.50M | |||
| Other Current Liabilities | 76.00K | 126.00K | null | null | null | |||
| Total Current Liabilities | 3.87M | 5.45M | 5.64M | 9.10M | 4.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.00K | 98.00K | 768.00K | 1.60M | 1.70M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 592.00K | 1.43M | 3.07M | 4.30M | 100.00K | |||
| Total Non-Current Liabilities | 596.00K | 1.53M | 3.84M | 5.90M | 1.80M | |||
| TOTAL LIABILITIES | 4.47M | 6.97M | 9.48M | 15.00M | 6.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -273.85M | -262.05M | -231.90M | -197.80M | -149.20M | |||
| Additional Paid In Capital | 301.18M | 300.45M | 297.00M | 302.20M | 296.00M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 100 | 3.00K | 3.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -11.10K | -13.00K | -209.00K | -1.00M | -300.00K | |||
| Shares Outstanding | 1.26M | 1.26M | 1.25M | 1.54M | 1.53M | |||
| Tangible Book Value per Share | 21.6556 | 30.4886 | 51.8534 | 3.3571 | 4.7876 | |||
| Total Shareholders' Equity | 27.31M | 38.39M | 64.89M | 103.40M | 146.50M | |||
| TOTAL LIABILITIES AND EQUITY | 31.78M | 45.36M | 74.37M | 118.40M | 153.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | |||
| Current Ratio | 7.64 | 7.70 | 11.92 | 11.93 | 30.31 | |||
| Return On Assets (ROA) | -84.39% | -66.48% | -45.85% | -41.04% | -24.01% | |||
| Return On Equity (ROE) | -98.20% | -78.56% | -52.55% | -46.99% | -25.11% | |||
All data in USD , ROIC based on taxRate of 0.21